New Location, Same Dedicated Care:
Waverly Hematology Oncology Announces Relocation of Clinic
Community oncology clinic relocates to continue providing enhanced cancer care to Wake County.
CARY, N.C., (August 2, 2022) – Community oncology practice Waverly Hematology Oncology (Waverly) announces the relocation of its clinic to 210 Ashville Avenue, Suite 440, in Cary effective August 1, 2022. The clinic will begin seeing patients, new and existing, starting August 2, 2022, at the new location.
“Our relocation comes from our steadfast growth and commitment to providing our patients with an environment that allows us to be patient-centered in our care approach,” said Dr. Mark Graham, leading medical oncologist and hematologist at Waverly. “We have been a part of Wake County for 18 years and are honored to continue serving our town and patients at our new clinic.”
Waverly’s new location, which is only a two-minute drive from the practice’s current location, is situated in the Medical Park of Cary, which houses other healthcare practices including complimentary care and services for oncology patients. The space has been designed specifically for delivering personalized cancer care to oncology and hematology patients.
“Great dedication has been taken during the setup process to ensure the space is well equipped to treat multiple cancer diagnoses and is an environment that inspires healing and wellness,” said Graham. “Cancer treatment can be an uncomfortable experience and physically and mentally taxing for patients, their families and their caregivers. We want to ensure that everyone who walks into our clinic feels a sense of peace and at home, which is the beauty and mission of community oncology.”
Waverly is a partner of the American Oncology Network (AON), which is an expanding network of community oncology practices across the United States. Since 2004, the clinic has offered medical oncology, chemotherapy, infusion therapy, laboratory services and an on-site pharmacy.
The practice also houses the oldest cancer genetics clinic in the county and is home to the area’s first formal cancer Survivor Clinic that serves over 2,000 breast cancer survivors and those at high risk for developing the disease. These services will continue to be available at the new location.
“We extend our appreciation to and applaud Waverly Hematology Oncology for their unwavering commitment to their community,” said AON Chief Executive Officer Todd Schonherz. “The relocation of their practice to a space that helps them deliver top-notch cancer care and treatment exemplifies their dedication to their patients as well as their mission to enhancing oncology in Cary and the surrounding communities.”
For more information about Waverly, visit www.waverlyhematologyoncology.com. For more information about AON, visit www.aoncology.com.
About Waverly Hematology Oncology
Waverly Hematology Oncology (Waverly) offers centralized easy access to cancer care for Cary, North Carolina patients and is conveniently located at the intersection of two major highways, Route 1 and Highway 64 (Tryon Road). In private practice since 2004, Waverly represents one medical oncologist four physician assistants and a team of over 40 employees, 17 of which have over 10 years of employment. A community-based practice, Waverly offers medical oncology, chemotherapy, infusion therapy, laboratory services, an on-site pharmacy and has the oldest cancer genetics clinic in Wake County. For over 30 years Dr. Graham has been an active clinical investigator through the NCI Community Oncology Research Program (NCORP), a cancer clinical trials network in the U.S., leading in patient accrual and data. Waverly is also the only Triangle site of the Southeast Clinical Oncology Research (SCOR), representing over 20 communities in six states. Waverly expanded the practice in 2015 and opened the first formal Cancer Survivorship Clinic in the county that now includes over 2,000 breast cancer survivors and those at high risk for breast cancer.
For over 30 years Dr. Graham has been an active clinical investigator through the NCI Community Oncology Research Program (NCORP), a cancer clinical trials network in the U.S., leading in patient accrual and data. Waverly is also the only Triangle site of the Southeast Clinical Oncology Research (SCOR), representing over 20 communities in six states.
Waverly expanded the practice in 2015 and opened the first formal Cancer Survivorship Clinic in the county that now includes over 2,000 breast cancer survivors and those at high risk for breast cancer.
About American Oncology Network, LLC
The American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology. Launched in 2018, the rapidly expanding AON network represents 108 physicians and 89 nurse practitioners and physician assistants practicing across 16 states. The executive management team of AON encompasses more than three decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care. AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.
Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Waverly Hematology Oncology Announces Relocation of Clinic